Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Rethinking Oncologic Trismus: Evidence for an Undermeasured Soft Tissue Phenotype.

Created on 20 Nov 2026

Authors

Holly McMillan, Richard Cardoso, Qian Xiao, Paula Cuccaro, Abigail Sedory, Clifton Fuller, Katherine Hutcheson

Published in

Head & neck. Nov 19, 2026. Epub Nov 19, 2026.

Abstract

Soft tissue impairment spanning the lymphedema-fibrosis continuum and trismus are highly prevalent head and neck cancer toxicities. While fibrosis is often implicated in trismus, no prior study has directly examined the association between clinician-graded head and neck lymphedema and fibrosis (HNL/F) and maximal interincisal opening (MIO).
HNL/F classifications and MIO were evaluated in 832 cancer survivors at a specialized Trismus Clinic (2020-2025). Spearman's correlation, ANOVA, univariate, and multivariate linear regression examined HNL/F-MIO relationships overall and by region (face, neck, and intraoral).
In unadjusted and adjusted analyses, all clinician-graded HNL/F classifications in the face were significantly associated with reduced MIO. In all regions, fibrosis was associated with reduced MIO in unadjusted models; after covariate adjustment, fibrosis remained significant, except in the neck.
These findings provide the first evidence linking regional and severity-based HNL/F classification with MIO and support HNL/F phenotyping in trismus assessment.

PMID:
43059079
Bibliographic data and abstract were imported from PubMed on 20 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement